Clinical trial
Hormone Therapy in Treating Women With Breast Cancer
NCT00003428 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003428 |
|---|---|
| Title | Hormone Therapy in Treating Women With Breast Cancer |
| Official title | Phase II Randomized Double-Blind Evaluation of Two Dose Levels of LY353381 Hydrochloride Administered to Women With Locally Advanced or Metastatic Breast Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | arzoxifene hydrochloride |
| Enrollment | 114 |
| Start date | May 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Sep 13, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: